An update on the pharmacotherapy of neovascular age-related macular degeneration

Author： Freund K Bailey Mrejen Sarah Gallego-Pinazo Roberto

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.8, 2013-06, pp. : 1017-1028

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hot Topics in Pharmacotherapy for Neovascular Age-Related Macular Degeneration

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 535-541

Bentham Science Publishers

Access to resources Recommend Favorite

Neovascular Age-Related Macular Degeneration: Potential Therapies

By Chappelow Aimee V. Kaiser Peter K.

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1029-1036

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of age-related macular degeneration (AMD)

By BertelmannThomas KaymakHakan

PHARMAKON, Vol. 3, Iss. 5, 2015-09 ,pp. : 388-399

Govi-Verlag

Access to resources Recommend Favorite

An update on photodynamic therapy in age-related macular degeneration

By Rechtman Ehud Ciulla Thomas A Criswell Mark H Pollack Ayala Harris Alon

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 931-938

Informa Healthcare

Access to resources Recommend Favorite

Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration

By Ohr Matthew Kaiser Peter K

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 585-591

Informa Healthcare

Access to resources Recommend Favorite